Other cancers with PTPN14 mutations include pancreatic adenocarcinomas, basal cell carcinomas, and relapsed neuroblastomas as well as 13.2% of cell lines in the NCI-60 set (36, –, 38). This evidence concerns the gene PTPN14 and cancer.